Know Better, Do Better: COVID-19 Vaccine Analytics

Since last Fall, we’ve been writing about the critical dimensions of COVID-19 vaccine distribution and management – including technology platforms, supply chain considerations, the need for community education and engagement, and contact management. With COVID-19 vaccine distribution well underway, we wanted to wrap this series with a post on vaccine analytics and reporting.

The first thing to note about vaccine reporting and analytics: This dimension isn’t a one-and-done exercise. By nature, it’s an ongoing process that should help illuminate trends and opportunities for further improvement. It also helps to provide timely updates to all levels of management and government leaders. And given the potential need for COVID-19 vaccine boosters, it’s become even more critical to stand up an effective and sustainable approach.

In working with counties and states, we recommend bringing together multiple data sources. The goal is a comprehensive, interconnected view of trends across health equity, vaccination journey and vaccine supply chain. Some of the most commonly used types of information include:

• Healthcare provider data – location, storage capacity and staffing capacity.
• Community demographic information – income, transportation, housing, employment, education and demographics.
• Vaccine inventory – available doses by manufacturer, including number of doses unused, spoiled, expired or wasted.
• Vaccine administration data – population demographics of people vaccinated, the number of complete and incomplete vaccinations and which manufacturers’ vaccines are being used.

<<< Start >>>

---

Accenture Vaccine Management Solution

READ MORE

---

<<< End >>>

Focusing on these areas will yield insights that state and local jurisdictions can use to:

• Manage vaccine allocation and distribution. How much vaccine is needed, and where? When will we have the vaccine in the dispensing locations? What’s the population per phase, per ZIP code? Where is there an over- or under-supply of vaccine?
• Assess healthcare facility readiness. Which health facilities are ready to accept shipments and administer the vaccine? For those not yet ready, what are the contributing factors?
• Address health equity. Where are there gaps in vaccination within the population? What are potential social barriers to vaccination (for example, homelessness and lack of transportation)? Are there societal/cultural barriers to vaccination? How might the jurisdiction adjust approaches to improve vaccine series completion?
• Improve community understanding and engagement. Have public health campaigns and education been effective? Does uptake differ by demographic? What’s the current vaccine sentiment within the population? Is there misinformation about the vaccine? What about differences between rural and urban areas?
• Understand vaccine impact. Is the vaccine effective at the population level? Are there any correlations with COVID positive cases and vaccine distribution? Are there variations in effectiveness and/or adverse events across different demographics?

These insights can be used to inform state and local decision-making throughout – and beyond – the initial round of vaccinations. The same processes and supporting technologies for vaccine reporting and analytics can be extended to support overall immunization and public health management.

As your jurisdiction continues to make progress with COVID-19 vaccines, we hope you’ll consider the value you can realize through effective reporting and analytics.

Reach out to us – Eyal and Kristin – via LinkedIn with any questions about how you can implement this kind of framework.

Read other blogs in this series:

<<< Start >>>

COVID-19 vaccines: Reaching every community

Kristin Thorn explains why equity should be the focal point for community engagement around COVID-19 vaccine distribution.

READ MORE

<<< End >>>

<<< Start >>>

Distributing COVID-19 Vaccines: Be Ready to Flex

Kristin Thorn explores the last-mile challenges faced in managing the COVID-19 vaccine supply chain.

READ MORE

<<< End >>>

<<< Start >>>

Strengthen COVID-19 vaccine distribution

Eyal Darmon and Kristin Thorn kick off a blog series about COVID-19 vaccines distribution.

READ MORE

<<< End >>>